Kyprolis for Multiple Myeloma, an Overview

Kyprolis, generic carfilzomib, is a new treatment specifically approved for multiple myeloma (MM) cancer, but with potential applications to other cancers. It works as a proteasome inhibitor and is the latest medication of that class approved for MM. The Disease MM is a serious cancer that, according to the American Cancer Society, is diagnosed in [...]